ImmuneBiotech
PrivateLast Round
Debt
Jul 8, 2026
Total Funding Raised
$165.79M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ImmuneBiotech is a biotechnology company that develops, markets, and commercializes therapeutically effective probiotic products designed with pharmaceutical precision to manage gastrointestinal and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Drug Discovery, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneBiotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ImmuneBiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 8, 2026 | ||||
| Growth Equity | May 4, 2026 | ||||
| VC Round | Jan 20, 2021 | ||||
| Series A | Jan 24, 2019 |
ImmuneBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Growth Equity |
| RA Capital Management | Growth Equity |
| Omega Funds | Growth Equity |
| Blue Owl Capital | Growth Equity |
| OrbiMed | Growth Equity |
| Almi Invest AB | Debt |
| Novo Holdings | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$165M round led by OrbiMed.
- Jan 2, 2026
Monthly visitors grew 206% MoM, from 53 to 162.
ImmuneBiotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuneBiotech's valuation, stock price, and market status.